FAMAR group expands its manufacturing footprint in northern Europe
FAMAR, a leading European pharmaceutical CDMO, is pleased to announce the closing of the acquisition of the sterile production site from MiP Pharma, located in Homburg, Germany, with the transfer of full ownership of the site to Famar.